Last reviewed · How we verify

Tiotropium Bromide Powder for Inhalation

Henan University of Traditional Chinese Medicine · Phase 3 active Small molecule

Tiotropium Bromide Powder for Inhalation is a Muscarinic antagonist Small molecule drug developed by Henan University of Traditional Chinese Medicine. It is currently in Phase 3 development for Chronic obstructive pulmonary disease (COPD).

Tiotropium bromide is a long-acting muscarinic antagonist that works by relaxing the airway muscles to improve breathing in patients with chronic obstructive pulmonary disease (COPD).

Tiotropium bromide is a long-acting muscarinic antagonist that works by relaxing the airway muscles to improve breathing in patients with chronic obstructive pulmonary disease (COPD). Used for Chronic obstructive pulmonary disease (COPD).

At a glance

Generic nameTiotropium Bromide Powder for Inhalation
SponsorHenan University of Traditional Chinese Medicine
Drug classMuscarinic antagonist
TargetM3 muscarinic receptor
ModalitySmall molecule
Therapeutic areaRespiratory
PhasePhase 3

Mechanism of action

It does this by blocking the action of acetylcholine at muscarinic receptors in the lungs, which leads to bronchodilation and improved lung function. This results in improved symptoms and quality of life for patients with COPD.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Tiotropium Bromide Powder for Inhalation

What is Tiotropium Bromide Powder for Inhalation?

Tiotropium Bromide Powder for Inhalation is a Muscarinic antagonist drug developed by Henan University of Traditional Chinese Medicine, indicated for Chronic obstructive pulmonary disease (COPD).

How does Tiotropium Bromide Powder for Inhalation work?

Tiotropium bromide is a long-acting muscarinic antagonist that works by relaxing the airway muscles to improve breathing in patients with chronic obstructive pulmonary disease (COPD).

What is Tiotropium Bromide Powder for Inhalation used for?

Tiotropium Bromide Powder for Inhalation is indicated for Chronic obstructive pulmonary disease (COPD).

Who makes Tiotropium Bromide Powder for Inhalation?

Tiotropium Bromide Powder for Inhalation is developed by Henan University of Traditional Chinese Medicine (see full Henan University of Traditional Chinese Medicine pipeline at /company/henan-university-of-traditional-chinese-medicine).

What drug class is Tiotropium Bromide Powder for Inhalation in?

Tiotropium Bromide Powder for Inhalation belongs to the Muscarinic antagonist class. See all Muscarinic antagonist drugs at /class/muscarinic-antagonist.

What development phase is Tiotropium Bromide Powder for Inhalation in?

Tiotropium Bromide Powder for Inhalation is in Phase 3.

What are the side effects of Tiotropium Bromide Powder for Inhalation?

Common side effects of Tiotropium Bromide Powder for Inhalation include Cough, Dysphonia, Headache, Nausea, Dyspnea.

What does Tiotropium Bromide Powder for Inhalation target?

Tiotropium Bromide Powder for Inhalation targets M3 muscarinic receptor and is a Muscarinic antagonist.

Related